Thumbnail Image
Publication

Prescription Drug Pricing in the United States: Drug Companies Profit at the Expense of Older Americans

House Committee on Government Reform
; 
Special Investigations Division
Abstract
The Special Investigations Division of the House Committee on Government Reform investigated prescription drug price discrimination and the impact on the elderly population. The investigation found older Americans who pay for their own drugs are charged more than the favored customers of drug companies such as health maintenance organizations and the federal government. Senior citizens were found to pay twice as much for drugs, which is a price differential that is six times greater than the average for consumer goods. Lastly, the Special Investigations Division found that pharmaceutical manufacturers were primarily responsible for the discriminatory practices that victimize older Americans who are least able to afford their prescriptions.
Date
1999-11-09
Document Type
House Minority Staff Report
Serial Number
Document Length
17 pages
Congress
106
Show all metadata
Files
Thumbnail Image
1999-11-09_R-Drug_Companies_Profit_at_the_Expense_of_Older_Americans-106C.pdf
Adobe PDF, 59.6 KB
Thumbnail Image
2000-05-09_FS-Drug_Companies_Profit_at_the_Expense_of_Older_Americans_Response-106C.pdf
Adobe PDF, 13.82 KB
URI
https://hdl.handle.net/20.500.14300/991
Relation
DOI
Keywords
Staff Reports, House, Democratic
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Related Hearings
Press Releases and Contextual Information
Collections
House Oversight Committee